Oral propranolol as a new treatment for facial infantile hemangioma: Case report

Rosane da Cruz Ferreira, Francisco Romeu Locatelli Wolff, Ricardo Mörschbächer

Research output: Contribution to journalArticle

Abstract

Hemangiomas are the most common benign tumors of infancy. Despite their selflimited course, infantile capillary hemangiomas can impair vital or sensory functions as vision and cause cosmetic deformity. The usual treatments include oral/intralesional steroids, alpha interferon, cytotoxins, pulsed dye laser and cosmetic surgery resection. These treatments are not free of multiple complications and toxic side effects. This report describes the case of a 3-month-old female baby with progressively increasing hemangioma of the left upper eyelid impinging over the visual field. The hemangioma promptly responded to low-dose oral propranolol. A clinical response was noticed few days after the beginning of the treatment, with regression to 1/4 of its original size in 45 days of treatment, and to less than 1/10 after 8 months, free of any major side effects.

Original languageEnglish (US)
Pages (from-to)207-208
Number of pages2
JournalArquivos Brasileiros de Oftalmologia
Volume74
Issue number3
DOIs
Publication statusPublished - Nov 22 2011
Externally publishedYes

    Fingerprint

Keywords

  • Capillary/therapy
  • Case reports
  • Hemangioma
  • Infant
  • Newborn
  • Propranolol/therapeutic use

ASJC Scopus subject areas

  • Ophthalmology

Cite this